63: Crizotinib for ALK rearrangement in non small cell lung cancer. (January 2017) - Merrick, S.A.; Hunter, S.; Dalby, M.; Neat, M.; McMunagle, E.; Montes, A.; Lal, R.; Ghosh, S.